Updated just now · Live
Stock analysis, price data, and AI-powered insights for Dogwood Therapeutics Inc (DWTX).
Dogwood Therapeutics Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for DWTX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). DWTX Stock Intelligence Report. [stoxpulse.com/stocks/dwtx]
Disclaimer: The information on this page about Dogwood Therapeutics Inc (DWTX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Dogwood Therapeutics Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
12 Health Care Stocks Moving In Thursday's After-M...
4d ago
Dogwood Therapeutics Announces FDA Acceptance Of I...
6d ago
StoxPulse AI results for DWTX: Pulse Score 49/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$53.4M
P/E Ratio
—
EPS
$-8.20
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
12 Health Care Stocks Moving In Thursday's After-Market Session
Dogwood Therapeutics Announces FDA Acceptance Of IND Application For Development Candidate SP16, Administered IV, For Treatment Of Chemotherapy-Induced Pain And Peripheral Neuropathy
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy